Skip to main content
Clinical Trials/IRCT2015102124470N1
IRCT2015102124470N1
Completed
Phase 1

A comparative study on the adverse reactions of purified chick embryo cell vaccine (PCEC) and purified vero cell rabies vaccine (VERO) administered intramuscular as post exposure prophylaxis

Center of Disease Control (CDC), Ministry of Health, Tehran, Iran0 sites1,800 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Rabies.
Sponsor
Center of Disease Control (CDC), Ministry of Health, Tehran, Iran
Enrollment
1800
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Center of Disease Control (CDC), Ministry of Health, Tehran, Iran

Eligibility Criteria

Inclusion Criteria

  • inclusion criteria: age between 5 and 55 years; volunteer to participate in the study.
  • exclusion criteria: have a history of previous animal bites; receiving immunization against rabies previously; have a significant acute or chronic infectious disease; receiving transfusion with blood or blood products within the past month; concomitantly receiving corticosteroids or immunosuppressive drug therapy; have axillary temperature 37\.5°C before injection; being pregnant in females

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials